When all 68 cases were evaluated as benign, borderline, and malignant ovarian tumors without considering histopathological subtypes, the p53, p21, bax and metallothionein showed significantly higher staining scores in the borderline and malignant tumors compared to the benign ones (p < 0.05). Here, TP53 is linked to ovarian cancer.